Complete Curriculum vitae (Opens as a new window):
http://person.au.dk/en/fsp@mb.au.dk/cv
Publication List 1997-2007 with Download Links:
http://www.mbio.au.dk/~fsp/Pub.htm
Appointments:
- 1973-1976 Research fellow at Department of Molecular Biology,
Aarhus University;
- 1976-1979/80 Post-doctoral research associate at Sidney Farber
Cancer Institute, Harvard Medical School, Boston, Mass., USA
(Laboratory of W.A. Haseltine).
- 1980-1995 Associate professor at Department of Molecular
Biology, Aarhus University.
- 1995-2005 Professor in oncological molecular biology,
Department of Molecular and Structural
Biology, Department of Medical Microbiology and Immunology,
University of Aarhus.
- 2005-Present Professor in Retroviral Molecular Biology,
Department of Molecular Biology, University of Aarhus
Other academic work:
- 176 international publications (excluding
abstracts), including 131 original scientific papers in peer
reviewed (mostly high-impact) journals, 9 peer-reviewed
survey-papers and 19 patents. 119 publications since 1994. Number
of NCBI entries for submitted nucleotide sequences: 590.
- Principal supervisor for 81 M.Sc. projects
and 45 Ph.D.‑projects (35 completed and 10 ongoimg).
- Grant application reviewer for many
national and international foundations; member of the Medical and
Scientific Board of the Danish Cancer Society, 2000-2005; member
of more than 10 review panels of the European Commission.
- Reviewer of on the average two manuscripts
per month for journals in molecular biology, genetics, virology,
cancer research, and biotechnology (e.g. Nature Methods, Nature
Struc. Biol., Nucl. Acids Res.. J. Mol. Biol., Oncogene, Human
Molecular Genetics, RNA).
- Member of numerous thesis committees and committees for
academic appointments, including eight professor appointments
Memberships, chairmanships:
- Contract partner i 4 successive EURATOM
shared cost research contracts (1983–1999);
- Corresponding member, European Late Effects
Project Group (1984-); Chairman, Biological Society of Jutland
(1985-93);
- Danish representative, Planning group for
gene technology, Nordic Council of Ministers (1988‑92);
- Representative, The National Committee for
Biochemistry (1988‑94);
- Board member, The Danish Centre for Human
Genome Research (1991‑98);
- Coordinator, international EC‑BRIDGE shared
cost research contract (retroviral vectors) (1991‑93 );
- Member of Danish Natural Science Academy
(1992‑); Administrative head (chairman) of the Dept. of Molecular
Biology, Aarhus University (1994‑95);
- Member of the executive board, Faculty of
Natural Science (1994‑95);
- Coordinator, EC‑Biotechnology‑2 shared cost
research contract (Retroviral vectors) (1995‑98);
- Sector coordinator, EC‑Biotechnology
Programme (Gene Therapy contracts, 1995‑98);
- Member, ACTIP (Animal Cell Technology
Industrial Platform (1995‑99);
- Contract partner, EC‑BioMed concerted
action (Gene therapy for AIDS, 1996‑99);
- Member, Scientific Advisory Board, Bavarian
Nordic Research Institute A/S (1997–2000) ;
- Member, Scientific Advisory Board, M & E
Biotech A/S (now Pharmexa) (1997–2000);
- Member of the Royal Danish Academy of
Sciences and Letters (1998‑);
- Member the Intellectual property board,
Aarhus University (1999‑2004);
- Member of the Medical and Scientific Board
of The Danish Cancer Society (2000-2005);
- Member of the patent board, Aarhus
University (2000-);
- Consultant to Sagres Discovery, Davis, CA,
USA (2000-2003):
- Advisor to Picobella LP, Burlingame, CA,
USA (2003- );
- Programme director of the Danish siRNA
Delivery Centre (2003- );
- Co-founder of Retrovec ApS (2004- );
- Member of the Advisory Board of the Center
for Molecular Clinical Cancer Research (2005-);
- Co-founder of InVitroQ ApS (2005);
- Member of the Evaluation committee
for Carlsbergs Mindelegat for Brygger J. C.
Jacobsen (2005-),
- Co-founder of EnFutech ApS (2007),
- Co-founder of SKAU Vaccines (2007),
- Panel evaluator for The Norwegian Cancer
Society (2007- 11).
Research interests:
- University of Aarhus, 1972-76:
Regulation of the synthesis of
guanosinetetra- and –pentaphosphates in Escherichia coli. Key
publication: Pedersen, F.S., Lund, E. &
Kjeldgaard N.O.: Codon specific tRNA dependent in vitro synthesis
of ppGpp and pppGpp. Nature (London) New Biol. 243, 13-15 (1973).
- Harvard Medical School, 1976–79/80:
Genome variation and biology of murine leukemia viruses and other
retroviruses. Key publication: Pedersen, F.S., Crowther, R.L.,
Tenney, D.Y., Reimold, A. & Haseltine, W.A.: Novel leukaemogenic
retroviruses isolated from a tumour cell line derived from a
spontaneous AKR tumour. Nature (London) 292, 167-170 (1981)
- Aarhus University, 1980–present:
Molecular retrovirology, including retroviral replication,
virus-host interactions, retroviral gene transfer and retroviral
pathogenicity. In the later years, the research also includes
other aspects of gene and cell technology. Has since 1980 authored
44 original papers in J. Virol., the
leading journal of experimental virology and 14 papers in
Virology, the second major journal of the field.
|
|
